Appointment of Joint Broker

RNS Number : 2284U
Dekeloil Public Limited
11 July 2018
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.  Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

DekelOil Public Limited / Index: AIM / Epic: DKL / Sector: Food Producers

11 July 2018

DekelOil Public Limited ("DekelOil" or the "Company")

Appointment of Joint Broker

 

DekelOil Public Limited, the West African focused agricultural company, is pleased to announce the appointment of VSA Capital as joint broker to the Company.

 

DekelOil Executive Director Lincoln Moore said, "We are delighted to bring on board VSA which has a strong pedigree in the agricultural sector, and in particular within the palm oil space.  We look forward to working with the VSA team, along with all our advisers, to ensure the underlying value of our portfolio of multi-stage projects is recognised by the market."

 

** ENDS **

 

For further information please visit the Company's website or contact:

 

DekelOil Public Limited

Youval Rasin

Shai Kol

Lincoln Moore

 

+44 (0) 207 236 1177

Cantor Fitzgerald Europe (Joint Broker)

David Foreman

Richard Salmond

+44 (0) 207 894 7000

VSA Capital (Joint Broker)

Andrew Monk (Corporate Broking)

Andrew Raca (Corporate Finance)

          +44 (0) 203 005 5000

Optiva Securities Limited (Joint Broker)

Christian Dennis

Jeremy King

 

+44 (0) 203 137 1903

St Brides Partners Ltd (Investor Relations)

Megan Dennison

Frank Buhagiar

+44 (0) 207 236 1177

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPEAXXEFEAPEFF
UK 100